Literature DB >> 14977977

CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Mairi C Noverr1, Peter R Williamson, Ryan S Fajardo, Gary B Huffnagle.   

Abstract

The pathogenic yeast Cryptococcus neoformans produces a laccase enzyme (CNLAC1), which catalyzes the synthesis of melanin in the presence of phenolic compounds. A number of genes have been implicated in the regulation of laccase and melanization, including IPC1, GPA1, MET3, and STE12. Albino mutants derived from random mutagenesis techniques may contain mutations in genes that regulate multiple virulence factors, including CNLAC1. The goal of our study is to investigate the role of CNLAC1 in virulence and evasion of pulmonary host defenses after infection via the respiratory tract. Using a set of congenic laccase-positive (2E-TUC-4) and laccase-deficient (2E-TU-4) strains, we found that both strains are avirulent at a lower dose (10(4) CFU/mouse) in mice. After the infectious dose was increased to 10(6) CFU/mouse, 70% mortality was observed in mice infected with 2E-TUC-4 compared to no mortality in mice infected with 2E-TU-4 at day 30 postinfection. This observation confirms the requirement for CNLAC1 in virulence. Interestingly, we observed no differences between the two strains in pulmonary growth or in elicitation of cellular immune responses in the lung. The only measurable defect of 2E-TU-4 was in dissemination to extrapulmonary sites. To examine the role of CNLAC1 in dissemination, mice were infected intravenously. By week 3 postinfection, equal numbers of strains 2E-TUC-4 and 2E-TU-4 were recovered from the brain and spleen. This observation indicates that CNLAC1 facilitates escape from the lung, but not growth in the lungs or brain, and suggests a novel role for CNLAC1 in virulence during an infection aquired via the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977977      PMCID: PMC356011          DOI: 10.1128/IAI.72.3.1693-1699.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Systemic cryptococcosis with solitary cutaneous lesion in an immunocompetent patient.

Authors:  R N Sampaio; B Medeiros; M Milfort; G F Alves; C M Reis; I T Campbell
Journal:  Int J Dermatol       Date:  1999-10       Impact factor: 2.736

2.  Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.

Authors:  Y Wang; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase.

Authors:  P R Williamson
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

4.  Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.

Authors:  A Yasuoka; S Kohno; H Yamada; M Kaku; H Koga
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

5.  Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line.

Authors:  E Blasi; R Barluzzi; R Mazzolla; B Tancini; S Saleppico; M Puliti; L Pitzurra; F Bistoni
Journal:  J Neuroimmunol       Date:  1995-04       Impact factor: 3.478

6.  Disseminated cryptococcosis in a patient with AIDS.

Authors:  T Reblin; A Meyer; H Albrecht; H Greten
Journal:  Mycoses       Date:  1994 Jul-Aug       Impact factor: 4.377

7.  Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans.

Authors:  G B Huffnagle; G H Chen; J L Curtis; R A McDonald; R M Strieter; G B Toews
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

8.  Cryptococcus neoformans melanin and virulence: mechanism of action.

Authors:  Y Wang; P Aisen; A Casadevall
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody.

Authors:  S C Lee; Y Kress; D W Dickson; A Casadevall
Journal:  J Neuroimmunol       Date:  1995-10       Impact factor: 3.478

10.  Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

View more
  53 in total

1.  Laccase expression in murine pulmonary Cryptococcus neoformans infection.

Authors:  Javier Garcia-Rivera; Stephanie C Tucker; Marta Feldmesser; Peter R Williamson; Arturo Casadevall
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 2.  Lipid signalling in pathogenic fungi.

Authors:  Arpita Singh; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2010-12-05       Impact factor: 3.715

3.  Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection.

Authors:  Guanggan Hu; Po-Yan Cheng; Anita Sham; John R Perfect; James W Kronstad
Journal:  Mol Microbiol       Date:  2008-07-30       Impact factor: 3.501

4.  Melanization of Fusarium keratoplasticum (F. solani Species Complex) During Disseminated Fusariosis in a Patient with Acute Leukemia.

Authors:  Siri Chiewchanvit; Siriporn Chongkae; Pongsak Mahanupab; Joshua D Nosanchuk; Soraya Pornsuwan; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  Mycopathologia       Date:  2017-06-14       Impact factor: 2.574

5.  The copper regulon of the human fungal pathogen Cryptococcus neoformans H99.

Authors:  Chen Ding; Jun Yin; Edgar Mauricio Medina Tovar; David A Fitzpatrick; Desmond G Higgins; Dennis J Thiele
Journal:  Mol Microbiol       Date:  2011-08-23       Impact factor: 3.501

6.  Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.

Authors:  Adithap Hansakon; Popchai Ngamskulrungroj; Pornpimon Angkasekwinai
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

7.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

8.  Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Authors:  Oliver W Liu; Cheryl D Chun; Eric D Chow; Changbin Chen; Hiten D Madhani; Suzanne M Noble
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

9.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

10.  Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans.

Authors:  Cheryl D Chun; Hiten D Madhani
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.